ArticleJournal of immunology research2022

A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma.

Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.